Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 2, 2019 (7 years ago)

10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Bag has the potential to leak.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13

Affected NDC 0409-7418-13

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
LMD in Dextrose
Dextran 40
NDC 00409-7418
10 g/100mL Injection, Solution
Intravenous
Hospira, Inc. Rx
Recalling firm
Pfizer Inc.
NDC code
0409-7418-13
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0136-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Pfizer Inc.

All 2019 recalls

Other sterility / contamination recalls from 2019

All sterility / contamination recalls